Rachel Stanton

Rachel Stanton has over 15 years of work experience in various scientific research roles. Rachel started their career as an Animal Technician at the Animal Resource Center at the University of California in 2001. In 2005, they worked as a Research Technician at Perry Scientific. From 2006 to 2008, Rachel served as a Research Associate I at Arena Pharmaceuticals, where they conducted pharmacokinetic studies and managed vivarium inventory.

In 2008, Rachel became a Regional Account Manager at Abaxis, where they successfully promoted and demonstrated clinical chemistry and hematology instruments in veterinary and research settings. Rachel generated sales and maintained customer relationships.

In 2009, Rachel joined Amylin Pharmaceuticals as a Research and Development Associate II. Rachel coordinated in-life metabolic screening assays and maintained accurate laboratory notebooks and quality control records.

From 2010 to 2012, Rachel worked as a Senior Associate Scientist and Scientist at Pfizer Biotherapeutics Research and Development. Rachel designed and coordinated in vivo metabolic experiments and explored the pharmacokinetic and pharmacodynamic relationship of antisense oligonucleotides. Rachel also conducted ex-vivo assays on non-human primate serum samples.

From 2013 to the present, Rachel has been employed as a Senior Research Associate II in Physiology at aTyr Pharma. Rachel coordinates and performs in vivo studies exploring the effects of drug candidates in various disease areas. Rachel has also piloted new protocols, developed in-house murine models, and evaluated the prophylactic and therapeutic effects of lead drug candidates.

Rachel Stanton earned a Bachelor of Science degree in Molecular Cell and Developmental Biology from UC Santa Barbara from 2000 to 2005. Additionally, they also obtained a BA in Environmental Studies from the same institution during the same time period. There is no information available regarding their education after their time at UC Santa Barbara.